These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 10917410)

  • 1. Risperidone for the treatment of stuttering.
    Maguire GA; Riley GD; Franklin DL; Gottschalk LA
    J Clin Psychopharmacol; 2000 Aug; 20(4):479-82. PubMed ID: 10917410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stuttering: neuropsychiatric features measured by content analysis of speech and the effect of risperidone on stuttering severity.
    Maguire GA; Gottschalk LA; Riley GD; Franklin DL; Bechtel RJ; Ashurst J
    Compr Psychiatry; 1999; 40(4):308-14. PubMed ID: 10428191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploratory randomized clinical study of pagoclone in persistent developmental stuttering: the EXamining Pagoclone for peRsistent dEvelopmental Stuttering Study.
    Maguire G; Franklin D; Vatakis NG; Morgenshtern E; Denko T; Yaruss JS; Spotts C; Davis L; Davis A; Fox P; Soni P; Blomgren M; Silverman A; Riley G
    J Clin Psychopharmacol; 2010 Feb; 30(1):48-56. PubMed ID: 20075648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A placebo-controlled trial of risperidone in Tourette syndrome.
    Scahill L; Leckman JF; Schultz RT; Katsovich L; Peterson BS
    Neurology; 2003 Apr; 60(7):1130-5. PubMed ID: 12682319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extrapyramidal symptoms in patients treated with risperidone.
    Simpson GM; Lindenmayer JP
    J Clin Psychopharmacol; 1997 Jun; 17(3):194-201. PubMed ID: 9169965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term safety and efficacy of risperidone for the treatment of disruptive behavior disorders in children with subaverage IQs.
    Turgay A; Binder C; Snyder R; Fisman S
    Pediatrics; 2002 Sep; 110(3):e34. PubMed ID: 12205284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alleviating stuttering with pharmacological interventions.
    Maguire GA; Yu BP; Franklin DL; Riley GD
    Expert Opin Pharmacother; 2004 Jul; 5(7):1565-71. PubMed ID: 15212606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risperidone for the treatment of cocaine dependence: randomized, double-blind trial.
    Grabowski J; Rhoades H; Silverman P; Schmitz JM; Stotts A; Creson D; Bailey R
    J Clin Psychopharmacol; 2000 Jun; 20(3):305-10. PubMed ID: 10831016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders.
    Shea S; Turgay A; Carroll A; Schulz M; Orlik H; Smith I; Dunbar F
    Pediatrics; 2004 Nov; 114(5):e634-41. PubMed ID: 15492353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute and continuation risperidone monotherapy in bipolar mania: a 3-week placebo-controlled trial followed by a 9-week double-blind trial of risperidone and haloperidol.
    Smulevich AB; Khanna S; Eerdekens M; Karcher K; Kramer M; Grossman F
    Eur Neuropsychopharmacol; 2005 Jan; 15(1):75-84. PubMed ID: 15572276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agonist-like or antagonist-like treatment for cocaine dependence with methadone for heroin dependence: two double-blind randomized clinical trials.
    Grabowski J; Rhoades H; Stotts A; Cowan K; Kopecky C; Dougherty A; Moeller FG; Hassan S; Schmitz J
    Neuropsychopharmacology; 2004 May; 29(5):969-81. PubMed ID: 15039761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized, placebo-controlled trial of risperidone for acute treatment of bipolar anxiety.
    Sheehan DV; McElroy SL; Harnett-Sheehan K; Keck PE; Janavs J; Rogers J; Gonzalez R; Shivakumar G; Suppes T
    J Affect Disord; 2009 Jun; 115(3):376-85. PubMed ID: 19042026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risperidone in children with autism: randomized, placebo-controlled, double-blind study.
    Nagaraj R; Singhi P; Malhi P
    J Child Neurol; 2006 Jun; 21(6):450-5. PubMed ID: 16948927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind, placebo-controlled study of risperidone in adults with autistic disorder and other pervasive developmental disorders.
    McDougle CJ; Holmes JP; Carlson DC; Pelton GH; Cohen DJ; Price LH
    Arch Gen Psychiatry; 1998 Jul; 55(7):633-41. PubMed ID: 9672054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risperidone in the treatment of behavioral disturbances in children and adolescents with borderline intellectual functioning: a double-blind, placebo-controlled pilot trial.
    Van Bellinghen M; De Troch C
    J Child Adolesc Psychopharmacol; 2001; 11(1):5-13. PubMed ID: 11322745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bl-1020, a new γ-aminobutyric acid-enhanced antipsychotic: results of 6-week, randomized, double-blind, controlled, efficacy and safety study.
    Geffen Y; Keefe R; Rabinowitz J; Anand R; Davidson M
    J Clin Psychiatry; 2012 Sep; 73(9):e1168-74. PubMed ID: 23059159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid antimanic effect of risperidone monotherapy: a 3-week multicenter, double-blind, placebo-controlled trial.
    Hirschfeld RM; Keck PE; Kramer M; Karcher K; Canuso C; Eerdekens M; Grossman F
    Am J Psychiatry; 2004 Jun; 161(6):1057-65. PubMed ID: 15169694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Risperidone Study Group.
    Katz IR; Jeste DV; Mintzer JE; Clyde C; Napolitano J; Brecher M
    J Clin Psychiatry; 1999 Feb; 60(2):107-15. PubMed ID: 10084637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety.
    Sachs GS; Grossman F; Ghaemi SN; Okamoto A; Bowden CL
    Am J Psychiatry; 2002 Jul; 159(7):1146-54. PubMed ID: 12091192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind placebo-controlled pilot study of risperidone for decreasing cue-elicited craving in recently withdrawn cocaine dependent patients.
    Smelson DA; Williams J; Ziedonis D; Sussner BD; Losonczy MF; Engelhart C; Kaune M
    J Subst Abuse Treat; 2004 Jul; 27(1):45-9. PubMed ID: 15223093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.